A phase II randomized trial of cobimetinib plus chemotherapy, with or without atezolizumab, as first-line treatment for patients with locally advanced or metastatic triple-negative breast cancer (COLET): primary analysis
Author:
Funder
F. Hoffmann-La Roche
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference32 articles.
1. Triple-negative breast cancer: clinical features and patterns of recurrence;Dent;Clin Cancer Res,2007
2. Triple-negative breast cancer;Foulkes;N Engl J Med,2010
3. Resistance to taxanes in triple-negative breast cancer associates with the dynamics of a CD49f+ tumor-initiating population;Gómez-Miragaya;Stem Cell Rep,2017
4. Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines;McDaid;Mol Pharmacol,2001
5. MEK inhibition enhances paclitaxel-induced tumor apoptosis;MacKeigan;J Biol Chem,2000
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Small molecule agents for triple negative breast cancer: Current status and future prospects;Translational Oncology;2024-03
2. Signaling mechanisms of chemoresistance in breast cancer stem cells for therapeutics;Cancer Stem Cells and Signaling Pathways;2024
3. Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression;BMC Chemistry;2023-11-22
4. Advances in immunotherapy for triple-negative breast cancer;Molecular Cancer;2023-09-02
5. Efficacy and Safety of Atezolizumab Monotherapy or Combined Therapy with Chemotherapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials;Current Pharmaceutical Design;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3